EUVIMEDEUVIMED entdecken
Crossref

Prospective Integration of Patient Preferences Into Adjuvant Therapy Decisions for Older Women With Early-Stage Hormone Receptor-Positive Breast Cancer Adjuvant Therapy Decisions in Breast Cancer

Andrea Brown, Sara Alcorn, Victoria Croog, Keara English, Mary Wilkinson, Princess Mark-Adjeli, Larissa Korde, Maureen O'Donnell, Hanh-Tam Tran, Catherine Westin, Jean L Wright

Practical Radiation Oncology · 2025

DOI: 10.1016/j.prro.2025.10.013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Practical Radiation Oncology, 2025. Verfasst von Andrea Brown und 10 weiteren Autor:innen. Beteiligte Einrichtung: Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland. Hauptthemen laut MEDLINE: Breast Neoplasms, Patient Preference, Decision Making. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Guidelines for women aged ≥65 years with early-stage, hormone receptor-positive cancer allow for a range of adjuvant strategies following breast-conserving surgery. These include hormone therapy (HT) with or without radiation therapy (RT), RT alone if HT is not desired or feasible, or even no adjuvant therapy. Although these options offer flexibility, they can also create uncertainty. To address this, we implemented a simple multidisciplinary clinic (s-MDC) with same-day medical and radiation oncology consultations, alongside a previsit questionnaire assessing decision-making preferences and treatment attitudes. METHODS AND MATERIALS: We evaluated 95 patients aged ≥65 years with stage I, hormone receptor-positive breast cancer seen in the s-MDC from August 2020 to December 2023. All completed the Decision Autonomy Preference Scale, Medical Maximizing-Minimizing Scale, and e-Prognosis 10-year mortality risk estimates. We retrospectively reviewed demographics, clinical variables, and chosen treatments, examining associations using χ2 tests, t tests, and regressions. RESULTS: Among 95 patients, adjuvant treatments included no therapy (16.8%), HT alone (16.8%), RT alone (20.0%), and HT+RT (45.3%). Older age, higher mortality risk, and a preference for decision autonomy correlated with omission of all therapy or omission of HT. "Minimizers" favored HT alone, whereas "maximizers" often chose RT or HT+RT. Neither baseline patient-reported data nor most clinicopathologic factors predicted the use of RT alone. The only clinicopathologic factor associated with choice was tumor size: patients with larger (T1b/T1c) tumors more commonly received HT+RT. CONCLUSIONS: In this s-MDC setting, treatment decisions were driven largely by patient preferences, life expectancy, and treatment inclinations, rather than by baseline patient-reported measures or tumor features. These findings underscore the importance of integrating patient values into decision-making and support further research into RT-alone approaches for those forgoing HT, given the prevalence of this treatment choice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsPatient PreferenceDecision MakingHumansFemaleAgedAged, 80 and overChemotherapy, AdjuvantProspective StudiesRetrospective StudiesReceptors, EstrogenRadiotherapy, AdjuvantReceptors, ProgesteroneNeoplasm Staging

Substanzen

Receptors, EstrogenReceptors, Progesterone

Autor:innen und Institutionen

  • Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland.
  • Department of Radiation Oncology, University of Minnesota, Minneapolis, Minnesota.
  • National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Department of Radiation Oncology, University of North Carolina, Chapel Hill, North Carolina. Electronic address: Jean_Wright@med.unc.edu.

Zitieren

APA

Brown, A., Alcorn, S., Croog, V., English, K., Wilkinson, M., Mark-Adjeli, P., Korde, L., O'Donnell, M., Tran, H. T., Westin, C., & Wright, J. L. (2025). Prospective Integration of Patient Preferences Into Adjuvant Therapy Decisions for Older Women With Early-Stage Hormone Receptor-Positive Breast Cancer Adjuvant Therapy Decisions in Breast Cancer. Practical Radiation Oncology. https://doi.org/10.1016/j.prro.2025.10.013

Vancouver

Brown A, Alcorn S, Croog V, English K, Wilkinson M, Mark-Adjeli P, et al. Prospective Integration of Patient Preferences Into Adjuvant Therapy Decisions for Older Women With Early-Stage Hormone Receptor-Positive Breast Cancer Adjuvant Therapy Decisions in Breast Cancer. Practical Radiation Oncology. 2025. doi:10.1016/j.prro.2025.10.013

BibTeX
@article{Brown2025,
  author = {Brown, Andrea and Alcorn, Sara and Croog, Victoria and English, Keara and Wilkinson, Mary and Mark-Adjeli, Princess and Korde, Larissa and O'Donnell, Maureen and Tran, Hanh-Tam and Westin, Catherine and Wright, Jean L},
  title = {Prospective Integration of Patient Preferences Into Adjuvant Therapy Decisions for Older Women With Early-Stage Hormone Receptor-Positive Breast Cancer Adjuvant Therapy Decisions in Breast Cancer},
  journal = {Practical Radiation Oncology},
  year = {2025},
  doi = {10.1016/j.prro.2025.10.013}
}
Kostenlos starten →